Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL

Abroad (travel likely)RecruitingPHASE2

Conditions

Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Natalia Mikhailova, MD, PhD

    Study Chair

    St. Petersburg State Pavlov Medical University